FDA clears RealView's Holoscope-i holographic system

By AuntMinnie.com staff writers

August 2, 2021 -- The U.S. Food and Drug Administration (FDA) has cleared Israeli 3D holographic display developer RealView Imaging's Holoscope-i medical holographic system.

Holoscop-i: Over-the-head Holographic system. Image courtesy of RealView Imaging.

Holoscope-i creates spatially accurate, 3D interactive medical holograms from CT and 3D ultrasound scan data, according to the vendor. The system is suspended above the physician rather than incorporated into an augmented or virtual reality headset or a stereoscopic screen, and it is based on RealView's Digital Light Shaping volumetric holography technology, the company said.

Is virtual reality in radiology becoming a reality?
Virtual reality is by no means a new technology, but recent developments have given it new life, enabling it to spread from gaming and consumer markets...
Philips, RealView wrap up 3D holographic study
Philips Healthcare and RealView Imaging have finished a clinical study evaluating the use of live 3D holographic imaging in interventional cardiology.

Copyright © 2021 AuntMinnie.com

Last Updated mf 8/3/2021 8:14:53 AM